Medpace Holdings (MEDP) Net Cash Flow Growth (1y) (2016 - 2026)
Medpace Holdings (MEDP) Net Cash Flow Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 498.33% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -260.86% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 73.93% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 722.22% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -115.29% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -58.16% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 73.12% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -441.96% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 84.25% |
| 10 | Medpace Holdings | 16.54 Bn | 16.03 Bn | 201.64 Mn | 62.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 62.26% |
| Mar 31, 2026 | 168.53% |
| Dec 31, 2025 | 1,355.04% |
| Sep 30, 2025 | 64.96% |
| Jun 30, 2025 | -481.75% |
| Mar 31, 2025 | -241.29% |
| Dec 31, 2024 | -90.33% |
| Sep 30, 2024 | 156.62% |
| Jun 30, 2024 | 1,378.01% |
| Mar 31, 2024 | 810.38% |
| Dec 31, 2023 | 4,199.56% |
| Sep 30, 2023 | 823.36% |
| Jun 30, 2023 | 78.51% |
| Mar 31, 2023 | 104.74% |
| Dec 31, 2022 | -105.70% |
| Sep 30, 2022 | -112.89% |
| Jun 30, 2022 | -734.44% |
| Mar 31, 2022 | -764.14% |
| Dec 31, 2021 | 11.56% |
| Sep 30, 2021 | 4.58% |